Are you Dr. Stevens?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 107 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3991 Dutchmans Ln
Suite 405
Louisville, KY 40207Phone+1 502-899-3366Fax+1 502-899-3455- Is this information wrong?
Summary
- Dr. Don Stevens, MD is an oncologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky, Indiana, and Maryland. He is affiliated with Norton Womens and Childrens Hospital, UofL Health - UofL Hospital, and Norton Children's Hospital.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1986 - 1988
- University of Louisville School of MedicineResidency, Internal Medicine, 1983 - 1986
- University of Louisville School of MedicineInternship, Transitional Year, 1982 - 1983
- University of Louisville School of MedicineResidency, Internal Medicine, 1982 - 1982
- University of Louisville School of MedicineClass of 1982
Certifications & Licensure
- KY State Medical License 1983 - 2025
- IN State Medical License 1991 - 2025
- MD State Medical License 1986 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
Clinical Trials
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Start of enrollment: 2010 May 01
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
- A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2020 Sep 03
- Join now to see all
Publications & Presentations
PubMed
- A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.Hammond, T., Purbhoo, M., Kadel, S., Ritz, J., Nikiforow, S., Daley, H., Shaw, K., van Besien, K., Gomez-Arteaga, A., Stevens, D., Ortuzar, W., Michelet, X., Smith, R....> ;Nature Communications. 2024 Feb 6
- 51 citationsElranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.Alexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, Nizar J Bahlis, H Miles Prince, Ruben Niesvizky, Paula Rodrίguez-Otero, Joaquin Martinez-Lopez, Guenther Koe...> ;Nature Medicine. 2023 Sep 1
- 3 citationsSafety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study.David Belada, Katerina Kopeckova, Juan Miguel Bergua Burgues, Don Stevens, Marc André, Ernesto Perez Persona, Petra Pichler, Philipp B Staber, Marek Trneny, Johannes D...> ;Blood. 2023 Oct 19
- Join now to see all
Press Mentions
- Tuesday, Dec 7 2021December 7th, 2021
- News Roundup: Vermont Dept. Of Health Reports 78 New COVID-19 CasesApril 22nd, 2021
- UVM Medical Center Pushing Forward with AstraZeneca COVID-19 Vaccine TrialMarch 15th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Norton HospitalLouisville, Kentucky
- Norton Womens and Childrens HospitalLouisville, Kentucky
- UofL Health - UofL HospitalLouisville, Kentucky
- Norton Children's HospitalLouisville, Kentucky